These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 12732871)

  • 1. Gene transfer approaches for the treatment of inflammatory bowel disease.
    Wirtz S; Neurath MF
    Gene Ther; 2003 May; 10(10):854-60. PubMed ID: 12732871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives.
    Neurath MF
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):81-4. PubMed ID: 10807047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
    Hibi T; Inoue N; Ogata H; Naganuma M
    J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
    Ghosh N; Chaki R; Mandal V; Lin GD; Mandal SC
    Int Rev Immunol; 2010; 29(1):4-37. PubMed ID: 20100080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disorders: gene therapy solutions.
    Wirtz S; Neurath MF
    Curr Opin Mol Ther; 2003 Oct; 5(5):495-502. PubMed ID: 14601518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the immunopathology of chronic inflammatory bowel disease.
    Ehrhardt RO
    Semin Gastrointest Dis; 1996 Jul; 7(3):144-50. PubMed ID: 8817766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune dysfunction in inflammatory bowel disease.
    Neuman MG
    Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunomodulation strategy targeted towards immunocompetent cells or cytokines in inflammatory bowel diseases (IBD).
    Heresbach D; Sémana G; Gosselin M; Bretagne MG
    Eur Cytokine Netw; 1999 Mar; 10(1):7-15. PubMed ID: 10210767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current dilemmas in the management of inflammatory bowel disease.
    Rutgeerts P
    Eur J Surg Suppl; 2002; (587):58-61. PubMed ID: 16144202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Standards, perspectives and limits of conservative therapy of chronic inflammatory bowel diseases].
    Rogler G; Andus T; Schölmerich J
    Zentralbl Chir; 1998; 123(4):316-24. PubMed ID: 9622888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biologic therapy of inflammatory bowel disease].
    Baumgart DC; Wiedenmann B; Dignass AU
    Z Gastroenterol; 2003 Oct; 41(10):1017-32. PubMed ID: 14562200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic and molecular mechanisms in inflammatory bowel disease.
    Ince MN; Elliott DE
    Surg Clin North Am; 2007 Jun; 87(3):681-96. PubMed ID: 17560420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of gut inflammation through the manipulation of intestinal dendritic cells and macrophages?
    Bar-On L; Zigmond E; Jung S
    Semin Immunol; 2011 Feb; 23(1):58-64. PubMed ID: 21292502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapies for inflammatory bowel disease: from the bench to the bedside.
    Danese S
    Gut; 2012 Jun; 61(6):918-32. PubMed ID: 22115827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving epidemiology of inflammatory bowel disease.
    Shanahan F; Bernstein CN
    Curr Opin Gastroenterol; 2009 Jul; 25(4):301-5. PubMed ID: 19349861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy.
    Fiocchi C
    Minerva Gastroenterol Dietol; 2002 Sep; 48(3):215-26. PubMed ID: 16491045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling for inflammation and repair in inflammatory bowel disease.
    Neuman MG
    Rom J Gastroenterol; 2004 Dec; 13(4):309-16. PubMed ID: 15624029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytapheresis in inflammatory bowel diseases: current evidence and perspectives.
    Danese S; Angelucci E; Stefanelli T; Omodei P; Luigiano C; Finazzi S; Pagano N; Repici A; Vecchi M; Malesci A
    Digestion; 2008; 77(2):96-107. PubMed ID: 18382085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.